Search research articles
Contact Us
Filters
Showing results (61-70 of 83) with videos related to
Page
of 9
Sort By:
Frontiers in Immunology
|
November 9, 2023
The efficacy and safety of cadonilimab combined with lenvatinib for first-line treatment of advanced hepatocellular carcinoma (COMPASSION-08): a phase Ib/II single-arm clinical trial
Qian Qiao, Chun Han, Sisi Ye, et al.
BMC Cancer
|
March 4, 2018
Safety assessment of sorafenib in Chinese patients with unresectable hepatocellular carcinoma: subgroup analysis of the GIDEON study
Sheng-Long Ye, Jiamei Yang, Ping Bie, et al.
Eclinicalmedicine
|
October 17, 2022
Ramucirumab as second-line treatment in Chinese patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib (REACH-2 China): A randomised, multicentre, double-blind study
Guoliang Shao, Yuxian Bai, Xianglin Yuan, et al.
BMC Cancer
|
December 8, 2020
Cancer patient management strategy in a Cancer Center of Zhejiang, China during the COVID-19 pandemic
Songxiao Xu, Xiangdong Cheng, Zhiwen Pan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 24, 2024
A Transformer-Based microvascular invasion classifier enhances prognostic stratification in HCC following radiofrequency ablation
Wentao Wang, Yueyue Wang, Danjun Song, et al.
Liver Cancer
|
June 16, 2023
Phase 2 Study of the PD-1 Inhibitor Serplulimab plus the Bevacizumab Biosimilar HLX04 in Patients with Previously Treated Advanced Hepatocellular Carcinoma
Zhenggang Ren, Guoliang Shao, Jie Shen, et al.
Oncotarget
|
January 7, 2016
Safety and efficacy of sorafenib therapy in patients with hepatocellular carcinoma: final outcome from the Chinese patient subset of the GIDEON study
Sheng-Long Ye, Xiaoping Chen, Jiamei Yang, et al.
Cancer Immunology, Immunotherapy : CII
|
January 3, 2025
Phase 2 study of serplulimab with the bevacizumab biosimilar HLX04 in the first-line treatment of advanced hepatocellular carcinoma
Zhenggang Ren, Guoliang Shao, Jie Shen, et al.
Hepatology (Baltimore, Md.)
|
July 5, 2014
Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial
Masatoshi Kudo, Guohong Han, Richard S Finn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 22, 2020
Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial
Jianming Xu, Jie Shen, Shanzhi Gu, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 83) with videos related to
Sort By:
Page
of 9
Frontiers in Immunology
|
November 9, 2023
The efficacy and safety of cadonilimab combined with lenvatinib for first-line treatment of advanced hepatocellular carcinoma (COMPASSION-08): a phase Ib/II single-arm clinical trial
Qian Qiao, Chun Han, Sisi Ye, et al.
BMC Cancer
|
March 4, 2018
Safety assessment of sorafenib in Chinese patients with unresectable hepatocellular carcinoma: subgroup analysis of the GIDEON study
Sheng-Long Ye, Jiamei Yang, Ping Bie, et al.
Eclinicalmedicine
|
October 17, 2022
Ramucirumab as second-line treatment in Chinese patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib (REACH-2 China): A randomised, multicentre, double-blind study
Guoliang Shao, Yuxian Bai, Xianglin Yuan, et al.
BMC Cancer
|
December 8, 2020
Cancer patient management strategy in a Cancer Center of Zhejiang, China during the COVID-19 pandemic
Songxiao Xu, Xiangdong Cheng, Zhiwen Pan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 24, 2024
A Transformer-Based microvascular invasion classifier enhances prognostic stratification in HCC following radiofrequency ablation
Wentao Wang, Yueyue Wang, Danjun Song, et al.
Liver Cancer
|
June 16, 2023
Phase 2 Study of the PD-1 Inhibitor Serplulimab plus the Bevacizumab Biosimilar HLX04 in Patients with Previously Treated Advanced Hepatocellular Carcinoma
Zhenggang Ren, Guoliang Shao, Jie Shen, et al.
Oncotarget
|
January 7, 2016
Safety and efficacy of sorafenib therapy in patients with hepatocellular carcinoma: final outcome from the Chinese patient subset of the GIDEON study
Sheng-Long Ye, Xiaoping Chen, Jiamei Yang, et al.
Cancer Immunology, Immunotherapy : CII
|
January 3, 2025
Phase 2 study of serplulimab with the bevacizumab biosimilar HLX04 in the first-line treatment of advanced hepatocellular carcinoma
Zhenggang Ren, Guoliang Shao, Jie Shen, et al.
Hepatology (Baltimore, Md.)
|
July 5, 2014
Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial
Masatoshi Kudo, Guohong Han, Richard S Finn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 22, 2020
Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial
Jianming Xu, Jie Shen, Shanzhi Gu, et al.
Page
of 9